News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Succès du financement de l'acquisition de DISTRAME : 100% des titres cédés
Logic Instrument finalise la cession des actions de Distrame acquises en novembre 2025 par la FPA, générant un profit direct. Distrame vise 30 M€ de CA avec un plan de développement axé sur partenariats, digitalisation, souveraineté logicielle et expansion -
-
COMMUNIQUÉ DE PRESSE
A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants
Japan approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as Prescription Drug for Vulnerable Infants, supported by clinical evidence and regulatory milestones -
-
-
-
COMMUNIQUÉ DE PRESSE
JOST implements its growth strategy AMBITION 2030 further and achieves strong results in all business lines in fiscal year 2025
JOST implements its growth strategy AMBITION 2030 further, achieving strong fiscal year 2025 results with 43.5% revenue rise, 28.6% EBIT increase, and record free cash flow
